ADENOSINE-CONTAINING COMPOSITION AND METHOD FOR SUPPRESSING PRECIPITATION OF ADENOSINE

Information

  • Patent Application
  • 20230293417
  • Publication Number
    20230293417
  • Date Filed
    August 16, 2021
    3 years ago
  • Date Published
    September 21, 2023
    a year ago
Abstract
An adenosine-containing composition contains (A) adenosine, (B) at least one selected from the group consisting of salicylic acid and salts thereof, glycyrrhizic acid and salts thereof, and plant extracts, and (C) water. The amount of ethanol is less than 20% by mass relative to the mass of the adenosine-containing composition.
Description
Claims
  • 1. An adenosine-containing composition comprising: (A) adenosine;(B) at least one selected from the group consisting of salicylic acid and salts thereof, glycyrrhizic acid and salts thereof, and plant extracts; and(C) water, wherein a content of ethanol is less than 20% by mass relative to the mass of the adenosine-containing composition.
  • 2. The adenosine-containing composition according to claim 1, wherein the plant extract is at least one selected from the group consisting of Angelica keiskei leaf/stem extract, Prunus armeniaca (apricot) juice, Ginkgo biloba leaf extract, Citrus unshiu peel extract, Scutellaria baicalensis root extract, Panax ginseng root extract, Rosa canina fruit extract, Ononis spinosa extract, Glycyrrhiza glabra (licorice) root extract, Phellodendron amurense bark extract, Sophora angustifolia root extract, Prunus speciosa leaf extract, Hypericum perforatum flower/leaf/stem extract, Crataegus monogyna flower extract, Aesculus hippocastanum (horse chestnut) seed extract, Achillea millefolium extract, Rosa centifolia flower extract, Prunus yedoensis leaf extract, Camellia japonica seed extract, Camellia japonica flower extract, Rubus suavissimus (raspberry) extract, Nelumbo nucifera germ extract, Syzygium jambos leaf extract, Bupleurum falcatum root extract, Melilotus officinalis extract, Centaurea cyanus flower extract, Citrus limon (lemon) extract, Rosmarinus officinalis (rosemary) extract, Rosmarinus officinalis (rosemary) leaf extract, Thymus serpyllum extract, and Sanguisorba officinalis extract.
  • 3. The adenosine-containing composition according to claim 1, wherein a content by percentage of the component (A) relative to the mass of the adenosine-containing composition is from 5 × 10-4% by mass to 8% by mass.
  • 4. The adenosine-containing composition according to claim 1, wherein the component (B) is a component which suppresses precipitation of the dissolved component (A).
  • 5. The adenosine-containing composition according to claim 1, wherein the component (B) further contains caffeine.
  • 6. The adenosine-containing composition according to claim 1, wherein a content by percentage of the component (B) relative to the mass of the adenosine-containing composition is 1 × 10-4% by mass or greater.
  • 7. The adenosine-containing composition according to claim 1, wherein a content by percentage of the component (C) relative to the mass of the adenosine-containing composition is 60% by mass or greater.
  • 8. The adenosine-containing composition according to claim 1, further comprising from 5% by mass to 40% by mass of a polyol relative to the mass of the adenosine-containing composition.
  • 9. The adenosine-containing composition according to claim 1, wherein: the composition is a single-phase liquid composition; andin atmospheric pressure at 25° C., the component (A) and the component (B) are dissolved in the adenosine-containing composition.
  • 10. The adenosine-containing composition according to claim 1, comprising substantially no ethanol.
  • 11. The adenosine-containing composition according to claim 1, wherein the composition is applicable in an external-use skin preparation applicable to the skin.
  • 12. The adenosine-containing composition according to claim 1, wherein the composition is an external-use skin preparation for application to the scalp.
  • 13. A method for suppressing precipitation of adenosine, comprising: dissolving adenosine and a first component to an aqueous solvent containing less than 20% by mass of ethanol, whereinthe first component is at least one selected from the group consisting of salicylic acid and salts thereof, glycyrrhizic acid and salts thereof, and plant extracts.
  • 14. The method according to claim 13, wherein, in the aqueous solvent, a content of water relative to the mass of the aqueous solvent is 60% by mass or greater.
  • 15. The method according to claim 13, wherein the plant extract is at least one selected from the group consisting of Angelica keiskei leaf/stem extract, Prunus armeniaca (apricot) juice, Ginkgo biloba leaf extract, Citrus unshiu peel extract, Scutellaria baicalensis root extract, Panax ginseng root extract, Rosa canina fruit extract, Ononis spinosa extract, Glycyrrhiza glabra (licorice) root extract, Phellodendron amurense bark extract, Sophora angustifolia root extract, Prunus speciosa leaf extract, Hypericum perforatum flower/leaf/stem extract, Crataegus monogyna flower extract, Aesculus hippocastanum (horse chestnut) seed extract, Achillea millefolium extract, Rosa centifolia flower extract, Prunus yedoensis leaf extract, Camellia japonica seed extract, Camellia japonica flower extract, Rubus suavissimus (raspberry) extract, Nelumbo nucifera germ extract, Syzygium jambos leaf extract, Bupleurum falcatum root extract, Melilotus officinalis extract, Centaurea cyanus flower extract, Citrus limon (lemon) extract, Rosmarinus officinalis (rosemary) extract, Rosmarinus officinalis (rosemary) leaf extract, Thymus serpyllum extract, and Sanguisorba officinalis extract.
  • 16. The method according to claim 13, wherein from 5×10-4% by mass to 8% by mass of adenosine is added to a total mass of composition.
  • 17. The method according to claim 13, wherein the first component is a component which suppresses precipitation of the dissolved adenosine.
  • 18. The method according to claim 13, wherein the first component further contains caffeine.
  • 19. The method according to claim 13, wherein 1 × 10-4% by mass or greater of the first component is added to the total mass of the composition.
  • 20. The method according to claim 13, further comprising adding, to the aqueous solvent, from 5% by mass to 40% by mass of a polyol relative to the total mass of the composition.
  • 21-22. (canceled)
Priority Claims (3)
Number Date Country Kind
2020-146939 Sep 2020 JP national
2021-002813 Jan 2021 JP national
2021-121685 Jul 2021 JP national
PCT Information
Filing Document Filing Date Country Kind
PCT/JP2021/029928 8/16/2021 WO